JY
CAPR icon

Jeff Yass’s Capricor Therapeutics CAPR Stock Holding History

Jeff Yass’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Buy
1,064,700
+12,900
+1% +$391K ﹤0.01% 2189
2026
Q1 		$32M Sell
1,051,800
-127,600
-11% -$3.4M ﹤0.01% 1673
2025
Q4 		$34M Sell
1,179,400
-50,800
-4% -$663K ﹤0.01% 1695
2025
Q3 		$8.87M Sell
1,230,200
-155,700
-11% -$1.15M ﹤0.01% 3192
2025
Q2 		$13.8M Buy
1,385,900
+1,283,200
+1,249% +$13.6M ﹤0.01% 2446
2025
Q1 		$975K Sell
102,700
-199,400
-66% -$2.77M ﹤0.01% 7321
2024
Q4 		$4.17M Buy
302,100
+40,500
+15% +$710K ﹤0.01% 3878
2024
Q3 		$3.98M Buy
261,600
+228,300
+686% +$1.13M ﹤0.01% 4004
2024
Q2 		$159K Sell
33,300
-43,200
-56% -$241K ﹤0.01% 10638
2024
Q1 		$519K Sell
76,500
-91,300
-54% -$441K ﹤0.01% 8410
2023
Q4 		$821K Buy
167,800
+62,100
+59% +$202K ﹤0.01% 7468
2023
Q3 		$361K Buy
105,700
+64,000
+153% +$360K ﹤0.01% 8961
2023
Q2 		$199K Sell
41,700
-4,300
-9% -$18.9K ﹤0.01% 10276
2023
Q1 		$194K Sell
46,000
-20,400
-31% -$87.8K ﹤0.01% 10631
2022
Q4 		$256K Sell
66,400
-49,100
-43% -$234K ﹤0.01% 9493
2022
Q3 		$693K Sell
115,500
-26,000
-18% -$133K ﹤0.01% 7592
2022
Q2 		$494K Sell
141,500
-2,200
-2% -$7.81K ﹤0.01% 8293
2022
Q1 		$493K Buy
143,700
+122,100
+565% +$482K ﹤0.01% 9017
2021
Q4 		$63K Sell
21,600
-148,600
-87% -$521K ﹤0.01% 12433
2021
Q3 		$684K Buy
+170,200
New +$775K ﹤0.01% 8579
2021
Q2 		– Sell
-35,800
Closed -$168K – 12584
2021
Q1 		$168K Sell
35,800
-36,300
-50% -$209K ﹤0.01% 11560
2020
Q4 		$247K Buy
72,100
+26,800
+59% +$116K ﹤0.01% 9669
2020
Q3 		$238K Buy
+45,300
New +$264K ﹤0.01% 9155

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jeff Yass's CAPR Position: Q2 2026 in Review

Jeff Yass reduced its Capricor Therapeutics (CAPR) stake by 82% in Q2 2026, selling an estimated $1.33M and leaving 9,462 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #11673.

Jeff Yass first reported a position in CAPR in Q4 2015 and has held it in 27 quarters since. The position peaked at $3.88M in Q4 2024. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Jeff Yass held 9,462 shares of Capricor Therapeutics worth $228K as of Q2 2026.
  • Jeff Yass sold 43,913 Capricor Therapeutics shares in Q2 2026, an estimated $1.33M.
  • Capricor Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11673 holding.
  • Jeff Yass first reported a position in Capricor Therapeutics in Q4 2015 and has held it in 27 quarters since.
  • Jeff Yass's Capricor Therapeutics position peaked at $3.88M in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.